Home » News » Karolinska Institute Sweden
The INFRAPLUS’s kick-off took place over two productive days in Munich. With lively discussions and concrete plans, we have set the stage for INFRAFRONTIER’s expansion in state-of-the-art in vivo models, innovative in vitro models, preclinical services, and data analysis. All set to get started!
A new publication of INFRAFRONTIER in Mammalian Genome is available on line now. Get an overview of the latest INFRAFRONTIER advancements, including services, resources, and technical developments.
Munich / Stockholm – Karolinska Institutet, one of the world´s leading medical universities selecting the Nobel Prize laureates in Physiology or Medicine every year, is now a co-owner of INFRAFRONTIER GmbH.
